These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Histopathology of gingival manifestations of hydantoin therapy]. Hanzély B Fogorv Sz; 1976; 69 Suppl():418-20. PubMed ID: 1071997 [No Abstract] [Full Text] [Related]
5. [Prospects of surgical treatment in hydantoin-induced gingival hyperplasia]. Wörle M Dtsch Zahnarztl Z; 1976 Nov; 31(11):881-3. PubMed ID: 1068797 [TBL] [Abstract][Full Text] [Related]
6. [On the pathomechanism of hydantoin-induced gingival hyperplasia]. Terner K; Tornai A; Tóth S Fogorv Sz; 1968 Aug; 61(8):228-34. PubMed ID: 5245442 [No Abstract] [Full Text] [Related]
7. [Clinical course and histological evaluation of hydantoin-induced gingival hyperplasia]. Bollobás E Fogorv Sz; 1986 Apr; 79(4):103-8. PubMed ID: 3457711 [No Abstract] [Full Text] [Related]
8. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy]. Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088 [No Abstract] [Full Text] [Related]
9. [Gingival hyperplasia induced by diphenylhydantoin. Clinical study of 106 cases]. Peñarrocha Diago M; Bagan Sebastian JV; Antolin Rodriguez MM; Alfaro Giner A Rev Eur Odontoestomatol; 1989; 1(1):41-8. PubMed ID: 2700619 [No Abstract] [Full Text] [Related]
10. The gingival hyperplasia resulting from diphenylhydantoin in children and adults. Matsumoto K; Nakagawa K; Kaneko Z Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242 [TBL] [Abstract][Full Text] [Related]
11. [Epilepsy, medical therapy and relation to dentistry. Report of 3 clinical cases of hydantoin gingival hypertrophy]. Levratti E; Simoncello P Minerva Ortognatod; 1990; 8(2):103-9. PubMed ID: 2278749 [TBL] [Abstract][Full Text] [Related]
12. [Oral hygiene and dental pathology due to hydantoin]. Weinstein R; Romeo E; Zandonella Necca S; Giuccioli D; Cornaggia C Prev Assist Dent; 1986; 12(4):7-11. PubMed ID: 3095818 [No Abstract] [Full Text] [Related]
13. [Factors involved in gingival hyperplasia caused by diphenyl hydantoin]. Mattioli A; Mauro S; Menetti L; Orlando S Minerva Stomatol; 1997 Oct; 46(10):525-32. PubMed ID: 9432558 [TBL] [Abstract][Full Text] [Related]
14. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation. Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021 [TBL] [Abstract][Full Text] [Related]
15. Gingival hyperplasia related to treatment with diphenylhydantoin (diphedan; DH). Rudas SL; Bárdos FV Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):180-4. PubMed ID: 4308214 [No Abstract] [Full Text] [Related]
17. The measured effect of phenytoin withdrawal on gingival hyperplasia in children. Brunsvold M; Tomasovic J; Ruemping D ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798 [TBL] [Abstract][Full Text] [Related]
18. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development. Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082 [No Abstract] [Full Text] [Related]
19. [Clinical statistical contribution on gingival hyperplasia caused by anticonvulsants]. Tollaro I Riv Ital Stomatol; 1968 Oct; 23(10):1519-53. PubMed ID: 5249714 [No Abstract] [Full Text] [Related]